ACE Inhibitors Market Overview

The Angiotensin-Converting Enzyme (ACE) Inhibitors Market is a significant segment within the pharmaceutical industry, primarily used to treat hypertension (high blood pressure) and heart failure. These medications work by inhibiting the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor. This mechanism of action leads to vasodilation, reduced blood pressure, and decreased cardiac workload.

ACE Inhibitors Market Drivers

ACE Inhibitors Market Restraints

ACE Inhibitors Market Opportunities

ACE Inhibitors Market Key Players

Pfizer Inc. (USA), Novartis International AG (Switzerland), Merck & Co., Inc. (USA), Sanofi S.A. (France), Johnson & Johnson (USA), AstraZeneca (UK), Bristol-Myers Squibb Company (USA), Abbott Laboratories (USA), Teva Pharmaceutical Industries Ltd. (Israel), Mylan N.V. (US

.

ACE Inhibitors Market Segmentation